Dong-A sees increased earnings for 1Q

Steadily improving brand recognition and regaining price competitiveness due to intensified cost-cutting efforts have helped boost the sales of Dong-A Pharmaceutical Co. in the first three months of the year

Although worries over Korean won’s fall against dollar still burdening major pharmaceutical firms, Dong-A has been drawing a better picture in the second quarter on expectations of incre...